© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 25, 2022
Take a look back at our most popular health system coverage for 2022.
November 14, 2022
As the main course of treatment for cancer-related pain, the use of opioids comes with a number of issues for both patients and prescribers.
Timing of treatment initiation is crucial for patients with cancer.
November 11, 2022
Collecting data on social determinants of health carries a number of issues and needs to be improved to create learning health systems.
While the use of chemotherapy at end of life is decreasing, the use of immunotherapy is increasing.
November 08, 2022
Follow-ups from pharmacists show a significant increase in outpatient antiemetic drugs prescribed and quality of life in patients experiencing chemotherapy-induced nausea and vomiting.
November 07, 2022
Tackling Medicare Part D drug costs takes more than just capping costs.
Childhood cancer survivors are high risk of pain and in need of pain relief. Did 2016 guidelines for opioid prescribing change use in this group?
September 12, 2022
Cancer care is expensive, but pharmacists can help.
August 05, 2022
This is the first approved therapy targeted to patients with the HER2-low breast cancer subtype. Its approval comes four months ahead of its PDUFA action date.